C Michael White

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 39

Top Venues

The Annals of pharmacotherapy

Journal of clinical pharmacology

Annals of internal medicine

Pharmacotherapy

University of Connecticut

Albany College of Pharmacy and Health Sciences (BSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Connecticut

United States

Professor :: Pharmacy Practice

Education History

Albany College of Pharmacy and Health Sciences

United States

BSC

Publications

Lyla R White, C Michael White
Eye Drop Quality Issues: Can the FDA See This One Through? The Annals of pharmacotherapy (2024)
Kimberly Snow Caroti, Alen Joseph, Amy Sapowadia, C Michael White
Elemental impurities (heavy metals) in kratom products: an assessment of published individual product analyses. Clinical toxicology (Philadelphia, Pa.) (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy (2024)
Jordyn Belcourt, Priscilla Ly, C Michael White
Bypassing Prescribers and Pharmacists: Online Purchasing of Semaglutide and Tirzepatide "For Research Purposes". The Annals of pharmacotherapy (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
C Michael White, Kimberly Snow Caroti, Youssef Bessada, Adrian V Hernández, William L Baker, Paul P Dobesh, Heleen van Haalen, Kirsty M Rhodes, Craig I Coleman
Andexanet alfa versus PCC products for factor Xa inhibitor bleeding: A systematic review with meta-analysis. Pharmacotherapy 44 (5) (2024)
Dakota J Sicignano, Ryan Kurschner, Nissen Weisman, Ava Sedensky, Adrian V Hernandez, C Michael White
The Impact of Ketamine for Treatment of Post-Traumatic Stress Disorder: A Systematic Review With Meta-Analyses. The Annals of pharmacotherapy (2023)
C Michael White
Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived. The Annals of pharmacotherapy (2023)
Dakota Sicignano, Kimberly Snow-Caroti, Adrian V Hernandez, C Michael White
The Impact of Psychedelic Drugs on Anxiety and Depression in Advanced Cancer or other Life-threatening Disease: A Systematic Review With Meta-analysis. American journal of clinical oncology (2023)
C Michael White, Nissen Weisman, Joseph Dalo
Psychedelics for Patients With Cancer: A Comprehensive Literature Review. The Annals of pharmacotherapy (2023)
Melody White, C Michael White
The Impact of Sedative Hypnotic Drugs on Hallucinated Sexual Assault or Sexual Fantasies Involving Health Professionals: A Systematic Review. Journal of clinical pharmacology (2023)
Joseph D Dalo, Nissen D Weisman, C Michael White
Mavacamten, a First-in-Class Cardiac Myosin Inhibitor for Obstructive Hypertrophic Cardiomyopathy. The Annals of pharmacotherapy (2022)
C Michael White
Pharmacists Have the Stats but No Provider Status: Now May Be Our Moment. The Annals of pharmacotherapy 56 (10) (2022)
C Michael White
Criminal Action Against Drug Counterfeiters: Assessment of the FDA Office of Criminal Investigation Database 2016 Through 2021. The Annals of pharmacotherapy 56 (12) (2022)
Kimberly W Smith, C Michael White
Inclisiran: A Novel Small Interfering RNA Drug for Low-Density Lipoprotein Reduction. Journal of clinical pharmacology 62 (9) (2022)
Anne N Nafziger, C Michael White
Drugs of Abuse: How Clinical Pharmacology Brings Clarity to the Shadows. Journal of clinical pharmacology (2022)
Kimberly W Smith, Dakota J Sicignano, Adrian V Hernández, C Michael White
MDMA-Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta-Analysis. Journal of clinical pharmacology (2021)
C Michael White, Lyla White
Response to letter to the editor by Dr Robinson. Journal of clinical pharmacology (2021)
C Michael White
Lead in Mineral or Multivitamin-Multimineral Products. The Annals of pharmacotherapy (2021)
C Michael White
Inflammation Suppresses Patients' Ability to Metabolize Cytochrome P450 Substrate Drugs. The Annals of pharmacotherapy (2021)
C Michael White, Lyla R White
Preventing a New Tuskegee: Food and Drug Administration Oversight of Overseas Research Must Match That in the United States. Journal of clinical pharmacology (2021)
C Michael White, Thom Browne, Anne N Nafziger
Inherent Dangers of Using Non-US Food and Drug Administration-Approved Substances of Abuse. Journal of clinical pharmacology (2021)
C Michael White, Dakota J Sicignano, Kimberly Smith
Impact of Interferons and Biological Drug Inhibitors of IL-2 and IL-6 on Small-Molecule Drug Metabolism Through the Cytochrome P450 System. The Annals of pharmacotherapy (2021)
C Michael White
Dietary Supplements Pose Real Dangers to Patients. The Annals of pharmacotherapy 54 (8) (2020)
C Michael White
Faulty Cell Lines Can Befuddle Clinical Pharmacology Decision-Making. Journal of clinical pharmacology (2020)
C Michael White
Current System of Overseeing Drug Trials in Developing Countries by the FDA Is Dangerous. The Annals of pharmacotherapy 54 (9) (2020)
Yuani M Roman, Adrian V Hernandez, C Michael White
The Role of Suppressing Inflammation in the Treatment of Atherosclerotic Cardiovascular Disease. The Annals of pharmacotherapy 54 (10) (2020)
Adrian V Hernández, Yuani M Roman, Vinay Pasupuleti, Joshuan J Barboza, C Michael White
Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19. Annals of internal medicine 173 (4) (2020)
C Michael White, Adrian V Hernandez
Why Your Patients' Believing Hydroxychloroquine and Chloroquine Are 90% Effective for COVID-19 Is 100% Dangerous. Journal of clinical pharmacology 60 (8) (2020)
Adrian V Hernández, Yuani M Roman, Vinay Pasupuleti, Joshuan J Barboza, C Michael White
Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19. Annals of internal medicine 173 (11) (2020)
Adrian V Hernandez, Yuani M Roman, C Michael White
Developing Criteria and Associated Instructions for Consistent and Useful Quality Improvement Study Data Extraction for Health Systems. Journal of general internal medicine 35 (Suppl 2) (2020)
Adrian V Hernández, Yuani M Roman, Vinay Pasupuleti, Joshuan J Barboza, C Michael White
Update Alert 2: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19. Annals of internal medicine 173 (7) (2020)
C Michael White, Kevin Chamberlin, Ellen Eisenberg
Curcumin, a turmeric extract, for oral lichen planus: A systematic review. Oral diseases 25 (3) (2019)
C Michael White
Generic Drugs Not as Safe as FDA Wants You to Believe. The Annals of pharmacotherapy 54 (3) (2019)
C Michael White
Understanding and Preventing (N-Nitrosodimethylamine) NDMA Contamination of Medications. The Annals of pharmacotherapy 54 (6) (2019)
C Michael White
Loperamide: A Readily Available but Dangerous Opioid Substitute. Journal of clinical pharmacology 59 (9) (2019)
C Michael White, Ji Young Lee
The impact of turmeric or its curcumin extract on nonalcoholic fatty liver disease: a systematic review of clinical trials. Pharmacy practice 17 (1) (2019)
C Michael White
Nurses must be aware of the potential for causing distress when recruiting vulnerable populations to research projects. Evidence-based nursing 22 (3) (2019)
C Michael White
The Pharmacologic Role and Clinical Utility of PCSK9 Inhibitors for the Treatment of Hypercholesterolemia. Journal of cardiovascular pharmacology and therapeutics 23 (4) (2018)

C Michael White.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

C Michael White